Live Breaking News & Updates on Healthy Late Preterm

Stay updated with breaking news from Healthy late preterm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations

Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus substantially reduced RSV lower respiratory tract. ....

United Kingdom , France General , United States , Comunidad Autonoma De Aragon , Sandrine Guendoul , Federico Martinon Torres , Thomas Kudsk Larsen , Sally Bain , Evan Berland , Nicolas Obrist , Tarik Elgoutni , Felix Lauscher , Corentine Driancourt , Nathalie Pham , Thomas Triomphe , Us Centers For Disease , Burden Of Community , Regulatory Agency , Vaccine Surveillance Network , China Center , Japan Agency For Medical Research , National Medical Products Administration , European Medicines Agency , European Union , California Perinatal Association , Drug Administration ,

Respiratory syncytial virus disproportionately affects pre-term infants over term infants

1. RSV-related ALRI incidence was significantly higher among preterm infants than term infants. 2. This pattern for RSV hospitalizations remained true until infants’ second year of life. Evidence Rating Level: 1 (Excellent) Study Rundown: Infants born prematurely face an increased risk for severe respiratory infections, particularly from respiratory syncytial virus (RSV). Until now, few studies ....

Global Health , Rating Level , Healthy Late Preterm , Acute Lower Respiratory Infections , Respiratory Infection , Rsv Bronchiolitis , Viral Illness , Infectious Disease ,

AstraZeneca Nirsevimab unanimously recommended by FDA Advisory Committee

AstraZeneca Nirsevimab unanimously recommended by FDA Advisory Committee ....

United Kingdom , United States , Ann Roberth Lurie , Thomas Triomphe , Beyfortus Nirsevimab , William Muller , Iskra Reic , National Medical Products Administration , Community Trials , Antimicrobial Drugs Advisory Committee Meeting , Northwestern University Feinberg School Of Medicine , China Center , Alliance Revenue , Centers For Disease , Lancet Child Adolesc Health , European Medicines Agency , Antimicrobial Drugs Advisory Committee , Sanofi Alliance , Japan Agency For Medical Research , Drug Administration , Advisory Committee , Biologics License Application , Prescription Drug User Fee Act , Associate Professor , Northwestern University Feinberg School , Scientific Director ,

RSV infection in infancy may increase the risk of developing early-onset childhood asthma

1. More patients in the RSV group reported asthma within 5 years compared to those in the non-RSV group. 2. Absence of a prior RSV infection decreased the 5-year risk of asthma by 26%. Evidence Rating Level: 2 (Good) Study Rundown: Respiratory syncytial virus (RSV) is a common childhood pathogen that may be linked to ....

United States , Rating Level , Healthy Late Preterm , Rsv Bronchiolitis , Chronic Disease , Infectious Disease ,

The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

RSV-associated acute respiratory infection causes substantial morbidity, leading to
the hospitalisation of one in every 56 healthy term-born infants in high-income settings.
Immunisation of pregnant women or healthy term-born infants during their first winter
season could have a major effect on the health-care burden caused by RSV infections. ....

South Africa , Sydkarelens Forbund , Norra Savolax , United Kingdom , Eastern Cape , Kilifi District , Rift Valley , South African , Graff Stensballe , Nybo Andersen , Lancet Glob Health , European Medicines Agency , A Prospective Community Study In Older Adults , Syncytial Virus Consortium In Europe , Englj Med , Syncytial Virus Vaccination , Healthy Late Preterm , Medicines Agency , Respiratory Syncytial Virus Infection , Population Based Cohort Study , Infect Dis , Prospective Birth Cohort , Glob Health , Acute Respiratory Infections , Respiratory Syncytial Virus Infection During , First Year ,